Steve Bagshaw has decided to retire from the CEO role and Martin Meeson will succeed him
FUJIFILM Diosynth Biotechnologies (FDB), a global CDMO, has announced that Steve Bagshaw, CEO of FDB, has decided to retire from his current position, effective 1 April 2020. Bagshaw will continue with the company in the role of Non-Executive Chairman.
Martin Meeson has been appointed by the FDB Executive Committee to succeed Bagshaw. Presently Meeson serves as President & COO of FDB, USA. Bagshaw, in his role of Non-Executive Chairman, will assist with the transition in executive leadership.
As an accomplished industry executive, Meeson has played a key role in the incredible growth and success of FDB. Meeson’s tenure at FDB began in 2008 when he joined the company as director of finance, IT and supply chain for the UK site. In 2013 he moved to the North Carolina site as Senior VP of Global Finance. During this period, he was closely involved in the acquisition FDB’s Texas facility.
Meeson was named President and COO of the US operations in 2015. In this role Meeson has spearheaded the company’s long term gene therapy growth strategy and driven significant investment for expansion at both the North Carolina and Texas facilities.
Before joining FDB, Meeson was Finance Director at Oxford Chemicals where he was responsible for all aspects of finance, IT, and purchasing. He has also held leadership positions at Hibernia Foods, ICI/DuPont and KPMG.
“FDB has an exciting future ahead. I am delighted to see Martin take on the role of CEO to lead the organisation in its future growth” said Bagshaw. “Martin has the skill set and experience to work with all of the FDB teams and our partners across the world to continue to deliver on our mission to advance tomorrow’s medicines.”
“I am honoured to be appointed to lead FDB at these exciting times,” said Martin Meeson, “I look forward to continue to work with the people and the partners that we have here at FDB. The mission that we share has been what has motivated me to be such a significant part of the leadership of this organisation over the last few years. Exciting times are ahead and the strength and energy of the people we have around us will continue to build our success as we move forward.”